ANDREW SUMMERS: Open Payments
NPI 1649958166 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$944 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $291 · 2025 $944
Food & beverage: $944
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 4 | $173 |
| Enterra Medical, Inc. | 1 | $141 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Madrigal Pharmaceuticals | 1 | $124 |
| Gilead Sciences, Inc. | 1 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $113 |
| ABBVIE INC. | 1 | $95 |
| QOL Medical, LLC | 1 | $39 |
| Ardelyx, Inc. | 1 | $21 |
Products named: TERLIVAZ, TREMFYA, REZDIFFRA, Livdelzi, ENTYVIO, RINVOQ, Sucraid, IBSRELA.
Industry payments across GA — which companies pay providers there.
